merscov
emerg
viru
alreadi
infect
human
high
mortal
show
except
potent
human
antimerscov
antibodi
almost
germlin
one
somat
mutat
heavi
chain
structur
fab
complex
merscov
receptorbind
domain
reveal
heavi
chain
provid
bind
surfac
epitop
almost
complet
overlap
receptorbind
site
analysi
antibodi
healthi
human
suggest
import
role
v
j
recombinationgener
junction
allelespecif
residu
achiev
high
affin
bind
low
level
somat
hypermut
result
also
import
implic
develop
vaccin
immunogen
base
newli
identifi
epitop
well
elucid
mechan
neutral
antibodi
elicit
vivo
figur
crystal
structur
fab
complex
merscov
rbd
complex
structur
cartoon
represent
heavi
light
chain
colour
light
green
light
blue
respect
receptorbind
subdomain
merscov
rbd
colour
orang
shown
shtick
represent
b
sequenc
heavi
chain
light
chain
residu
interact
merscov
rbd
highlight
orang
dot
antibodi
residu
number
accord
kabat
nomenclatur
c
interact
cdr
merscov
rbd
cdr
shown
cartoon
represent
merscov
rbd
depict
semitranspar
surfac
cartoon
detail
interact
patch
merscov
rbd
key
residu
highlight
stick
represent
hydrogen
bond
salt
bridg
display
dot
line
connect
interact
atom
noncanon
disulphid
bond
residu
yellow
stick
panel
c
shown
differ
panel
recent
discoveri
neutral
monoclon
antibodi
mab
except
potenc
breadth
human
immunodefici
influenza
renew
interest
design
vaccin
elicit
similar
antibodi
vivo
howev
vaccin
develop
imped
fact
broadli
neutral
antibodi
bnab
highli
diverg
put
germlin
predecessor
design
germlin
antibodi
show
littl
measur
bind
viral
antigen
interestingli
neutral
antibodi
emerg
virus
includ
sever
acut
respiratori
syndrom
coronaviru
sarscov
nipah
hendra
virus
caus
acut
infect
could
elicit
within
rel
short
period
time
infect
antibodi
close
put
germlin
predecessor
therefor
structur
character
interact
germlinelik
antibodi
virus
may
repres
uniqu
opportun
understand
initi
elicit
mechan
bnab
may
eventu
help
design
effect
vaccin
immunogen
middl
east
respiratori
syndrom
coronaviru
merscov
novel
highli
pathogen
human
coronaviru
first
recogn
septemb
saudi
arabia
patient
exhibit
sarslik
respiratori
syndrom
die
sever
pneumonia
renal
failur
sinc
septemb
mer
case
report
countri
laboratoryconfirm
case
report
world
health
organ
june
includ
least
relat
death
http
note
merscov
phylogenet
distinct
human
coronaviru
includ
sarscov
relat
bat
coronavirus
ref
other
found
merscov
like
origin
bat
adapt
use
human
receptor
dipeptidyl
gain
entri
host
cell
dromedari
camel
middl
east
africa
consid
one
intermedi
transmitt
merscov
bat
human
inde
found
coronavirus
abl
rapidli
stabli
adapt
new
host
speci
find
along
fact
merscov
emerg
decad
appear
first
highli
pathogen
human
coronaviru
sarscov
higher
mortal
rate
versu
suggest
coronavirus
could
continu
longterm
threat
human
health
therefor
other
develop
human
neutral
mab
viru
use
candid
therapeut
templat
vaccin
immunogen
well
tool
understand
immun
respons
newli
emerg
viru
potent
mab
bound
merscov
receptorbind
domain
rbd
subnanomolar
avid
inhibit
infect
pseudotyp
live
merscov
inhibitori
concentr
requir
neutral
ic
mg
ml
respect
studi
analys
immunogenet
origin
solv
crystal
structur
complex
merscov
rbd
antibodi
precis
target
receptorbind
site
rb
merscov
rel
signific
number
three
junction
residu
heavychain
complementaritydetermin
region
two
allelespecif
germlineencod
residu
critic
rbd
bind
germlin
mab
typic
exhibit
excel
drugabl
properti
especi
lower
immunogen
therefor
mab
may
effect
templat
develop
vaccin
immunogen
also
could
great
potenti
prophylaxi
therapi
merscov
infect
human
crystal
structur
merscov
rbd
complex
fab
elucid
molecular
mechan
merscov
neutral
identifi
possibl
templat
develop
vaccin
immunogen
determin
crystal
structur
complex
viru
rbd
robot
screen
crystal
condit
endoglycosidas
htreat
merscov
rbd
complex
fab
crystal
diffract
qualiti
obtain
condit
contain
monomethyl
polyethylen
glycol
mme
resolut
data
set
space
group
collect
beamlin
advanc
photon
sourc
glycerol
cryoprotect
structur
solut
molecular
replac
merscov
rbd
fab
reveal
two
fab
rbd
complex
occupi
asymmetr
unit
iter
refin
model
build
result
structur
r
work
r
free
tabl
supplementari
fig
fab
target
merscov
rb
fab
interact
rb
merscov
rbd
fig
interact
surfac
buri
total
area
contribut
merscov
rbd
even
though
heavychain
variabl
domain
v
h
lightchain
variabl
domain
v
l
involv
interact
v
h
provid
bind
surfac
within
v
h
framework
region
provid
total
merscov
rbdbind
surfac
v
j
recombin
product
provid
fig
side
antigenbind
region
form
clawshap
surfac
claw
grip
rb
penetr
concav
surfac
form
interact
outer
edg
entranc
loop
fig
note
noncanon
disulphid
bond
form
kabat
number
definit
stabil
twist
loop
conform
fig
similar
receptor
interact
patch
rb
fig
similar
rbd
recognit
epitop
compos
residu
merscov
rbd
rb
includ
strand
loop
lead
fig
overlap
extens
site
pairwis
comparison
ligandbind
surfac
area
rb
residu
either
epitop
site
show
signific
correl
p
indic
share
usag
residu
bind
receptor
rb
residu
interact
pairwis
surfac
area
buri
show
even
stronger
correl
p
fig
inde
epitop
surfac
overlap
site
rb
fig
supplementari
fig
interestingli
rbd
interact
glycan
engag
residu
residu
importantli
addit
precis
target
rb
critic
chemic
interact
salt
bridg
rbd
mimick
fig
supplementari
tabl
rbdbind
surfac
show
basic
electrostat
potenti
fig
superposit
rbd
form
form
result
ca
root
mean
squar
deviat
rmsd
indic
bind
induc
signific
conform
chang
merscov
rbd
interest
note
similar
conform
antibodi
epitop
even
higher
rest
merscov
rbd
ca
rmsd
superposit
merscov
rbd
also
brought
overlap
posit
fab
encompass
volum
fig
supplementari
fig
indic
immunogenet
analysi
perform
immunogenet
analysi
use
imgt
tool
determin
closest
v
h
v
l
germlin
gene
junction
amino
acid
v
h
fig
found
v
h
gene
deriv
v
l
gene
remark
v
h
gene
almost
germlin
except
point
mutat
one
nonsil
nucleotid
mutat
lead
chang
asparagin
asn
serin
ser
posit
found
deriv
allel
phenylalanin
phe
lysin
ly
residu
natur
encod
allel
either
found
togeth
alon
allel
interestingli
gene
dominantli
use
number
antivir
antibodi
includ
target
epitop
influenza
ha
sarscov
rbd
henipavirus
allelespecif
residu
compris
germlin
contribut
paratop
v
h
fig
importantli
genet
structur
analys
show
v
h
specif
junction
residu
posit
encod
amino
acid
valin
val
asn
arginin
arg
glycin
gli
respect
fig
play
domin
role
elucid
crystal
structur
fig
notabl
merscov
rbd
eakpsgsvveqaegvecdfspllsgtppqvynfkrlvftncnynltkllslfsvndftc
merscov
rbd
qispaaiasncysslildyfsyplsmksdlsvssagpisqfnykqsfsnptclilatvph
contact
merscov
rbd
nlttitkplkysyinkcsrflsddrtevpqlvnanqyspcvsivpstvwedgdyyrkql
epitop
contact
somat
mutat
ighd
ighj
gene
unambigu
identifi
imgtvquest
supplementari
tabl
contrast
v
l
compos
found
five
amino
acid
residu
chang
five
nonsil
three
silent
nucleotid
mutat
result
mutat
igkv
gene
fig
supplementari
tabl
howev
none
v
l
somat
mutat
found
directli
involv
bind
rbd
possibl
could
influenc
v
h
v
l
interact
result
alloster
effect
detail
structur
analysi
complex
structur
reveal
residu
particularli
junction
residu
involv
hydrogen
bond
rbd
respect
mimick
conserv
interact
fig
b
supplementari
tabl
also
junction
residu
form
salt
bridg
resembl
conserv
slat
bridg
involv
fig
b
supplementari
tabl
summari
show
germlineencod
residu
conserv
mani
allel
importantli
junction
residu
make
conserv
interact
could
play
critic
role
paratop
interact
find
suggest
select
specif
junction
amino
acid
certain
v
j
recombin
allelespecif
amino
acid
heavi
chain
subsequ
somat
mutat
light
chain
could
lead
high
affin
target
rbd
howev
adapt
somat
light
chain
arvgycsstscnrgafdi
arvgycsstschigafdi
arasycsttscasgafdi
araqycsstscywnwfdp
ivenf
arveycsstscyanwfdp
aragycsstscysswfdp
ardgycsstscyfryfdl
alngycsstscwvlpfdp
argmycsstscygpafdi
argqycsstscylyafdi
argrycsstsckddafdi
cdbvv
mutat
might
depend
natur
junction
residu
occur
far
ahead
somat
mutat
determin
pathway
affin
matur
investig
potenti
immunogenet
mechan
recombin
frequenc
specif
ighd
ighj
gene
among
germlin
conserv
amino
acid
residu
allel
junction
posit
analys
detail
deep
sequenc
data
antibodyom
studi
healthi
human
donor
analysi
reveal
signific
proport
express
v
h
gene
product
recombin
gene
supplementari
fig
among
total
sequenc
germlin
origin
sequenc
germlineencod
sequenc
germlineencod
natur
allel
residu
popul
individu
sequenc
residu
found
suggest
potenti
mechan
contribut
individu
variabl
effect
elicit
neutral
antibodi
respons
merscov
infect
explor
v
h
sequenc
antibodi
sequenc
databas
find
v
h
relat
antibodi
found
nine
v
h
sequenc
volunt
share
germlin
famili
characterist
disulphid
bond
middl
fig
common
among
includ
similar
length
amino
acid
usag
segment
notabl
uniqu
junction
motif
compar
nine
v
h
sequenc
well
two
antimerscov
antibodi
recent
report
fig
disulphid
bond
character
gene
conserv
impli
ighd
read
frame
usag
nine
v
h
sequenc
disulphidebond
cystein
residu
involv
direct
bind
merscov
rbd
fig
suggest
possibl
function
role
disulphid
motif
compar
antimerscov
antibodi
use
differ
v
l
deriv
wherea
use
respect
v
l
sequenc
although
antibodi
phage
display
techniqu
prove
effect
method
gener
mab
mab
obtain
random
combin
v
h
v
l
may
reflect
natur
v
h
v
l
pair
found
immun
repertoir
assess
potenti
compat
v
h
v
l
pair
search
found
v
h
v
l
pair
exist
dengu
crossreact
hybridomaderiv
mab
antihomo
sapien
epiderm
growth
factor
receptor
egfr
antibodi
imgatuzumab
indic
immunolog
relev
cognat
v
h
v
l
pair
type
examin
role
usag
v
l
analys
lineag
sequenc
retriev
naiv
igm
repertoir
healthi
human
subject
well
neonat
igm
repertoir
two
newborn
babi
found
uniqu
v
l
like
sequenc
lineag
share
preexist
amino
acid
mutat
v
l
supplementari
fig
phylogenet
tree
analysi
v
l
like
sequenc
reveal
highli
germlinerel
natur
v
l
fig
previous
found
heavi
light
chain
one
five
amino
acid
chang
natur
occur
somat
hypermut
cord
blood
igm
repertoir
interest
aspect
studi
v
l
mutat
also
found
preexist
mutat
associ
certain
lineag
sequenc
igm
repertoir
supplementari
fig
identifi
antirabi
viru
antibodi
blast
search
genbank
databas
whose
v
l
chain
four
mutat
ident
v
l
compar
germlin
impli
possibl
function
role
v
l
mutat
accordingli
v
l
mutat
although
lesser
extent
along
uniqu
junction
residu
allel
encod
residu
v
h
might
play
role
highaffin
bind
merscov
taken
togeth
result
suggest
v
h
use
key
immunogenet
element
includ
natur
occur
allelicspecif
amino
acid
specif
junction
amino
acid
residu
v
l
reli
somat
mutat
deriv
high
affin
unpreced
manner
bind
neutral
activ
germlin
precursor
surpris
except
potent
merscov
neutral
six
amino
acid
chang
infer
germlin
precursor
determin
whether
mutat
essenti
potenc
revert
residu
heavi
chain
light
chain
lightchain
framework
region
germlin
counterpart
respect
fig
bind
germlin
predecessor
recombin
merscov
protein
evalu
enzymelink
immunosorb
assay
elisa
fig
biacor
supplementari
fig
neutral
activ
merscov
virus
cell
determin
use
method
previous
describ
fig
revers
mutat
heavi
chain
effect
merscovbind
affin
neutral
activ
exhibit
potent
neutral
activ
ic
mg
ml
similar
measur
mg
ml
describ
previous
mg
ml
light
chain
contain
three
somat
mutat
framework
region
two
region
none
residu
make
direct
contact
merscov
rbd
interestingli
revers
three
framework
somat
mutat
germlin
counterpart
decreas
bind
merscov
rbd
fig
also
markedli
reduc
neutral
potenc
fig
neutral
activ
ic
mg
ml
two
order
magnitud
lower
ic
mg
ml
complet
revers
somat
mutat
v
l
decreas
rbdbind
activ
merscovneutr
activ
interestingli
dissoci
rate
constant
four
antibodi
similar
associ
rate
constant
much
higher
supplementari
fig
ic
valu
mg
ml
threefold
higher
consist
immunogenet
analysi
result
support
import
natur
occur
v
l
mutat
demonstr
noncontact
residu
light
chain
essenti
bind
potenc
bind
activ
junction
allelespecif
mutant
demonstr
import
junction
allelespecif
residu
bind
rbd
gener
seri
mutat
measur
bind
merscov
protein
elisa
fig
f
deriv
allel
allel
eight
phenylalanin
posit
six
allel
leucin
interestingli
mutant
found
greatli
reduc
bind
affin
merscov
protein
least
reduc
compar
wildtyp
fig
similarli
half
allel
lysin
posit
allel
glutam
acid
mutant
found
least
reduc
merscov
bind
affin
compar
alanin
mutat
four
junction
amino
acid
also
show
sever
reduc
bind
merscov
compar
wildtyp
fig
result
along
structur
analysi
confirm
junction
allelespecif
amino
acid
critic
merscov
rbd
bind
viru
neutral
elicit
highli
somat
mutat
bnab
virus
high
antigen
divers
hiv
challeng
tradit
vaccin
approach
appli
thu
altern
vaccin
strategi
propos
first
activ
naiv
matur
b
cell
express
unmut
germlin
b
cell
receptor
germlin
antibodybind
immunogen
follow
immunogen
bind
intermedi
antibodi
guid
immun
system
complex
matur
pathway
result
final
elicit
antibodi
specif
sequenc
howev
appear
potent
antibodi
broad
neutral
activ
virus
case
articl
merscov
natur
exist
low
level
somat
hypermut
merscov
rbd
highli
conserv
mutat
analys
known
rbd
sequenc
found
epitop
overlap
point
mutat
supplementari
fig
use
genet
structur
analys
discov
germlineencod
antibodi
could
achiev
highaffin
recognit
neutral
newli
emerg
merscov
mostli
use
allelespecif
residu
well
junction
amino
acid
noteworthi
even
though
germlin
sequenc
specif
antibodi
exampl
bnab
predict
reconstruct
b
cell
clonal
lineag
may
possibl
infer
exact
natur
occur
junction
amino
acid
introduc
v
j
rearrang
critic
process
preced
somat
hypermut
therefor
junction
amino
acid
matur
antibodi
usual
retain
bioinformat
deriv
design
germlineencod
precursor
antibodi
notabl
demonstr
adapt
somat
mutat
might
depend
natur
junction
amino
acid
occur
far
ahead
somat
mutat
could
determin
matur
pathway
antibodi
find
coupl
fact
matur
antibodi
virus
exampl
highli
somat
mutat
suggest
junction
residu
matur
antibodi
may
quit
differ
initi
germlin
counterpart
phenomenon
could
import
consequ
elicit
bnab
therefor
propos
altern
strategi
identifi
natur
occur
germlin
predecessor
bnab
explor
human
antibodyom
rather
theoret
reconstruct
therebi
confound
ration
design
otherwis
effect
vaccin
immunogen
interestingli
also
found
uniqu
junction
amino
acid
compar
relat
v
hs
identifi
deep
sequenc
antibodyom
healthi
human
well
recent
identifi
antimerscov
antibodi
origin
junction
amino
acid
play
import
role
directli
involv
interact
merscov
rbd
particularli
junction
amino
acid
particip
antigen
recognit
exampl
form
salt
bridg
merscov
rbd
critic
highaffin
interact
key
immunogenet
element
includ
natur
occur
allelicspecif
amino
acid
also
identifi
play
role
highaffin
bind
merscov
rbd
result
suggest
direct
antigen
recognit
effect
junction
residu
could
affect
subsequ
somat
hypermut
matur
pathway
antibodi
consid
design
germlineencod
precursor
antibodi
relat
vaccin
strategi
result
also
demonstr
junction
divers
specif
allel
potenti
contribut
individu
differ
humor
immun
respons
key
cofactor
select
potent
neutral
antibodi
identif
germlinelik
potent
merscovneutr
antibodi
impli
elicit
neutral
antibodi
respons
immun
could
rel
quick
effect
crystal
structur
merscov
rbd
complex
fab
also
show
bound
area
rb
merscov
rbd
encompass
patch
patch
residu
epitop
almost
complet
overlap
bind
site
natur
receptor
mimick
critic
interact
merscov
rbd
also
exploit
angl
approach
recognit
similar
achiev
potent
neutral
reason
specul
develop
viral
escap
mutant
unfavour
sinc
reduc
bind
mutant
virus
could
also
result
reduc
bind
cellular
receptor
thu
epitop
rbd
identifi
may
aid
develop
highli
effect
merscov
vaccin
antibodi
due
germlin
natur
could
great
potenti
prophylaxi
therapi
merscov
infect
human
protein
express
purif
merscov
rbd
ctermin
cleavag
site
purif
tag
express
gnti
cell
merscov
rbd
protein
purifi
nickelnitrilotriacet
acid
ninta
affin
chromatographi
follow
size
exclus
chromatographi
use
pb
buffer
mutant
gener
use
quikchang
ii
xl
sitedirect
mutagenesi
kit
stratagen
plasmid
templat
mutant
gener
fabexpress
plasmid
templat
light
chain
synthes
genscript
piscataway
nj
insert
plasmid
respect
replac
origin
light
chain
antibodi
express
analys
protein
puriti
estim
sdspolyacrylamid
gel
electrophoresi
protein
concentr
measur
spectrophotometr
nanovu
ge
healthcar
crystal
data
collect
antigenbind
fragment
antibodi
prepar
use
lysc
roch
digest
igglysc
ratio
ww
rbd
protein
mix
fab
molar
ratio
incub
min
room
temperatur
complex
purifi
size
exclus
chromatographi
superdex
ge
healthcar
concentr
mg
ml
crystal
screen
initi
crystal
carri
use
mosquito
crystal
robot
ttp
labtech
uk
commerci
avail
hampton
hampton
research
precipit
synergi
emerald
biosystem
wizard
emerald
biosystem
crystal
screen
droplet
allow
equilibr
imag
schedul
time
rock
imag
formulatrix
robot
crystal
hit
optim
manual
use
hang
drop
vapordiffus
method
crystal
diffract
qualiti
obtain
mix
ml
protein
complex
ml
reservoir
solut
contain
monomethyl
polyethylen
glycol
mm
hepe
ph
diffract
data
crystal
collect
cryogen
condit
buffer
contain
monomethyl
polyethylen
glycol
mm
hepe
ph
glycerol
cryoprotect
beamlin
sercat
advanc
photon
sourc
argonn
nation
laboratori
radiat
resolut
data
set
process
scale
ref
space
group
structur
determin
refin
structur
merscov
rbd
complex
solv
molecular
replac
use
phaser
program
suit
place
two
copi
rbd
complex
asymmetr
unit
merscov
rbd
pdb
id
use
initi
model
locat
merscov
protein
cdrlooptrim
variabl
domain
fab
pdb
id
constant
domain
use
separ
locat
correspond
domain
fab
structur
refin
carri
phenix
cross
valid
r
free
test
set
contain
data
start
torsionangl
simul
anneal
slow
cool
iter
manual
model
build
carri
coot
map
gener
combin
posit
individu
bfactor
tl
refin
algorithm
order
solvent
ad
macro
cycl
structur
valid
perform
period
model
buildingrefin
process
molprob
final
refin
statist
summar
tabl
elisa
bind
antibodi
merscov
protein
sino
biolog
inc
measur
elisa
serial
fivefold
dilut
antibodi
start
mm
dilut
pb
assay
bind
merscov
protein
wash
bound
antibodi
detect
horseradish
peroxidas
hrp
conjug
goat
antihuman
igg
ab
sigmaaldrich
cat
horseradish
peroxidaseconjug
antiflag
ab
sigmaaldrich
cat
surfac
plasmon
reson
bind
surfac
plasmon
reson
measur
perform
use
biacor
instrument
ge
healthcar
merscov
protein
sino
biolog
inc
dilut
mm
sodium
acet
buffer
ph
immobil
biosensor
chip
use
primari
amin
coupl
method
run
buffer
allow
flow
cell
rate
ml
min
analyt
consist
serial
dilut
protein
nm
nm
neutral
assay
measur
neutral
activ
cell
infect
merscov
pseudovirus
presenc
serial
dilut
antibodi
indic
concentr
cultur
refe
fresh
medium
h
post
infect
incub
addit
h
cell
wash
pb
lyse
use
lysi
reagent
includ
luciferas
kit
promega
aliquot
cell
lysat
transfer
flatbottom
luminomet
plate
costar
follow
addit
luciferas
substrat
promega
rel
light
unit
determin
immedi
use
ultra
luminomet
tecan
usa
immunogenet
analysi
antibodi
cdna
librari
construct
peripher
blood
b
cell
healthi
donor
sequenc
use
sequenc
technolog
inform
consent
obtain
human
particip
detail
qualiti
control
highthroughput
sequenc
analysi
igm
antibodi
variabl
domain
consist
three
cdr
along
fr
elabor
elsewher
briefli
imgthighvquest
use
immunogenet
sa
sa
institut
cari
nc
use
statist
analys
output
result
imgthighvquest
analysi
store
local
postgresql
databas
structur
queri
languag
sql
use
retriev
lineag
sequenc
immunogenet
analysi
sequenc
align
made
phylogenet
tree
analysi
perform
use
archaeopteryx
